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CObjective: To describe a method for imputing missing follow-up blood
pressure data in a clinical hypertension trial using blood pressures
abstracted from medical charts. Methods: We tested a two-step
ethod. In the first, a longitudinal mixed-effects model was estimated
n blood pressures abstracted from medical charts. In the second, the
atient-specific fitted values from thismodel at follow-upwere used to
mpute blood pressures missing at follow-up in the trial. Simulations
hat imposed alternative missing data mechanisms on observed trial
ata were used to compare this approach to imputation approaches
hat do not incorporate data from charts. Results: For data that are
issing at random, incorporating the fitted values from chart-based lon-
itudinalmodels leads to estimates of the trial-basedbloodpressures that O
the D
140
al So
oi:10.1016/j.jval.2011.05.049re unbiased andhave lowermean squared deviation thando blood pres-
ures imputedwithout the chart-baseddata. For data that aremissingnot
t random, incorporating fitted values ameliorates but does not eliminate
he inherent missing data bias. Conclusions: Incorporating chart data
nto an imputation algorithm via the use of longitudinal mixed-effects
odel is an efficient way to impute longitudinal data that are missing
rom a randomized trial.
eywords: blood pressure, clinical trials, imputation, longitudinal data,
issing data.
opyright © 2011, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
When a substantial percent of patients in a randomized trial fail to
show up for their follow-up visit, the resulting missing outcome
data can seriously confound the interpretation of the results of the
trial [1–3]. Statistical techniques for handlingmissing data, such as
single ormultiple imputation (MI), can yield unbiased estimates of
treatment effectiveness in the presence of missing data [2–11],
provided that the missing data conform to a missing at random
(MAR) mechanism. The MAR assumption holds that the probabil-
ity that some outcome data is missing can depend on other ob-
served variables, but not on the value of the outcome itself, con-
ditional on the observed variables. That is, after controlling for
other observed variables, the value of the outcome variable is not
a predictor ofmissingness. MAR is a generally untestable assump-
tion [12], and whether it holds or not depends in part on the other
observed variables available to the researcher. Themore pertinent
information a researcher has about the potentially missing out-
come value, the more likely the MAR assumption is to hold.
Just such pertinent information may be available in patient
medical charts, and utilizing this information may improve our
ability to validly impute missing trial data. For example, a patient
who fails to report for a follow-up blood pressure reading in a
hypertension trial may nevertheless continue to keep appoint-
ments with his or her clinician who records the patient’s blood
† The work was conducted while Dr. Hebert was assistant professor in
Y, USA
* Address correspondence to: Paul L. Hebert, 1100 Olive Way, Suite
E-mail address: Paul.Hebert2@va.gov.
098-3015/$36.00 – see front matter Copyright © 2011, Internation
ublished by Elsevier Inc.pressure and other signs and symptoms in the medical chart in
the course of routine medical care. It seems reasonable that these
chart-based blood pressure readings should be useful for imputing
themissing trial-based blood pressure readings, but incorporating
the chart-based blood pressures into an imputation algorithm is
complicated by two factors. First, the trial protocol specifies that
the blood pressures be taken at specific times during the trial, and
while the patient may have clinic visits before and after these
times, she or hemay not have a visit during the specific window of
time when the trial blood pressure was scheduled to take place.
Second, the blood pressure recorded in the medical chart may be
systematically different than the blood pressure that would have
been recorded by trial personnel. Trial protocols, personnel, and
equipment for recording blood pressure are standardized,
whereas clinic procedures and equipment can vary from one pro-
vider to the next. In addition, so-called white coat hypertension
[13] may cause blood pressure readings in clinicians’ offices to be
systematically higher than those taken by trial personnel because
patients’ blood pressures respond to the anxiety associated with
seeing a clinician.
The goal of this article is to describe a novel method for over-
coming these two challenges to using chart-based information to
impute data missing from a clinical trial, and to assess via simu-
lation the utility of this method compared to standardmethods of
imputing missing trial data. We apply this method to the imputa-
epartment of Health Policy at Mount Sinai School of Medicine, New York,
0, Seattle, WA 98101 USA.
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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1086 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 0 8 5 – 1 0 9 1tion of missing blood pressure data from a hypertension trial. The
method involves first specifying a mixed effects longitudinal
model of blood pressure measurements taken from medical
charts for each patient. From this model we recover the fitted
value (both the fixed and random components) of patients’ pre-
dicted blood pressures for the days the patients were scheduled
for follow-up blood pressure measurements in the trial. We then
use these data in either a single- or multiple-imputation frame-
work to impute missing trial blood pressure measurements.
The article is organized into two parts. In the first part we de-
scribe themethod and apply it to data from the trial. In the second
part we conduct simulations to assess the utility of this new
method compared to other commonly used imputation methods.
Data and Methods
Data
The data come from a randomized trial of nurse-led disease man-
agement for patients with uncontrolled hypertension in east and
central Harlem in New York City. In this trial, 416 patients were
randomized to receive usual care, a home blood pressuremonitor,
or a home blood pressure monitor plus follow-up counseling by a
trained nurse. The outcomeswere blood pressure at 9months and
18months,whichwere taken in person by trained study personnel
with standardized equipment and procedures. These systolic and
diastolic readings are referred to as trial-based blood pressures.
Patients also consented to have their blood pressure and other
medical information abstracted from their medical charts from 1
year before and 18 months after enrollment in the trial. These
readings are referred to as chart-based blood pressures.
Methods: Combining chart- and trial-based blood pressures Incorpo-
rating chart-based blood pressures into an imputation algorithm
requires several steps. In the first stepwe estimated amixed effect
linearmodel of chart-based blood pressure as a function of time as
shown in equation (1)
Yit
c 01t2t
2u0iu1it eit (1)
Where Ycit is systolic blood pressure for patient i recorded from a
medical chart at time t, which is days since enrollment in the trial;
negative values represent pre-enrollment times. Time and its
square appear as fixed effects in equation (1) to capture the overall
trend in chart-based blood pressures over time.
Patient-specific random intercepts u0i and random slopes u1i
capture the idiosyncratic mean and trajectory of blood pressure
for each patient. More complex models that involved higher pow-
ers of time and random slopes for the t2 term were also investi-
ated, but the specification of equation (1) was chosen based on
he Bayesian Information Criterion. We assumed an unstructured
ovariancematrix for the random effects to allow for a correlation
etween the random slopes and intercepts, and estimated the pa-
ameters using restricted maximum likelihood.
In the second step,we calculated the fitted value of equation (1)
t t  274 and t  548, which correspond to 9 months and 18
onths after trial entry, when patients in the trial were scheduled
or a follow-up blood pressure measurement. These fitted values
ncluded estimates for the fixed components aswell as predictions
f the random components u0i and u1i. These fitted values are
hrinkage estimators of what the systolic blood pressure would
ave been for a specific patient if that patient had an outpatient
isit on the day she or he was scheduled for a follow-up blood
ressure reading from study personnel. Shrinkage estimators are
seful in this context because the estimates for patients with few
hart-based blood pressuremeasurementswithwhich to estimate
n individual specific trend are “shrunk” toward the population
ean estimated trend [14]. vIn the third step, we tested if these fitted values are useful for
redicting trial-based blood pressures at 9- and 18-month fol-
ow-up. We estimated a base model (equation 2a) that is a linear
egression of trial-based blood pressure at follow-up month m
m  9,18) as a function of baseline characteristics Xi, baseline
rial-based systolic blood pressure Ysi0, and a dummy variable
I18 (m) that is equal to one if month  18 and zero otherwise.
ote that equation (2a) has no data in common with equation
1). The former uses chart-based blood pressure as the depen-
ent variable and contains no covariates other than continuous
easures of time. The latter uses trial-based blood pressure,
ncludes patient baseline characteristics, and represents time
y a dummy variable.
We then estimated a comparison model (equation 2b) that in-
luded the fitted values Yˆcim from equation (1) as an additional
xplanatory variable, and recorded the additional variance ex-
lained by this model in terms of adjusted R2. We used robust
standard errors clustered on the patient to account for the maxi-
mum of two observations per patient.
Ym
s 01X12Yi0
s 3l18 (m) vim (2a)
m
s 01Xi2Yi0
s 3l18(m)4Yˆim
c  vim (2b)
esults: Combining chart- and trial-based blood pressures Table 1
hows that 416 patients enrolled in the trial at baseline and 152
admissing blood pressure readings at either 9 or 18months after
nrollment. Women and Hispanics were less likely to be missing
t follow-up, and systolic blood pressure at baseline was some-
hat higher among patients who would eventually miss a fol-
ow-up reading. These 416 patients had 3345 blood pressure read-
ngs recorded inmedical charts during outpatient visits during the
years surrounding the trial, with a large number occurring before
nd after the trial. Slightly lower blood pressure readings were
ecorded at routine outpatient visits than during visits with trial
ersonnel.
Table 2 shows a comparison of longitudinal models for trial-
ased blood pressure, which correspond to equations (2a) and (2b)
bove. Each patient who completed a follow-up interview is in-
luded in this model; a patient who completed both the 9- and
8-month interview contributes two observations to the models.
he first column of Table 2 shows coefficients and P values from a
inear regression where the dependent variable was systolic blood
ressure and explanatory variables included baseline characteris-
ics of trial participants. The second column shows the same
odel with the addition of the fitted values from the chart-based
ystolic blood pressure model (this model is available from the
uthor) as an explanatory variable. The addition of the fitted val-
es adds significantly to the explanatory power of the model, as is
emonstrated by the substantial increase in the adjusted R2, from
.102without the chart-based fitted values to 0.264with them. The
ignificant decrease in the coefficient on baseline blood pressure
n model (2b) compared to (2a) likely reflects that the chart-based
tted values is picking up some of the variance explained by base-
ine trial-based blood pressure. A similar benefit of including fitted
alues from the chart-based model is shown for diastolic blood
ressure in columns three and four.
Methods: Simulation to compare imputationmethods that incorporate
hart-based data with standard imputation methodsNext, we ran sim-
lations to explore whether using these chart-based fitted values
n a single or multiple imputation algorithm improved the quality
f the imputation of trial blood pressures. The strategy was to
orce twomissing datamechanisms on the trial-based blood pres-
ure data—a MAR mechanism and a missing not at random
MNAR) mechanism—and then compare how various imputation
ethods performed under these scenarios. To do this we first es-
imated a logit model where the dependent variable was a time-
arying indicator for whether the patient’s trial-based blood pres-
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1087V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 0 8 5 – 1 0 9 1sure data wasmissing at month 9 or 18, as shown in equation (3a).
We then limited the dataset to only those patients with observed
follow-up blood pressures.We calculated a scenario-modified pre-
dicted probability (Pˆim) of being missing at months m  9,18 for
ach patient as shown in equation (3b)
r(Missingim 1) f(01X12Yi0
s 3l18(m)) (3a)
Pˆim f(ˆ0ˆ1X1ˆ2Yi0
s ˆ3l18(m)Y im
s ) (3b)
where f() is the logistic function,  are the estimated coefficients
rom (3a) and Y sim are observed systolic trial-based blood pressures
t month m for patient i transformed to a standard normal vari-
ble. By setting  equal to different values we can affect anMAR or
MNAR pattern of missing data on the observed data. Setting   0
ffects an MAR missing data mechanisms while  further from
ero implies data that are MNAR. For example,  log (1.5) has the
effect of increasing the odds of beingmissing at follow-up 1.5-fold
for every one standard deviation increase over the mean in ob-
served study blood pressure at follow-up. Because the standard
deviation of systolic blood pressure was 16.8 and the probability of
missingwas set at 25%, this implied that a patient whose observed
blood pressure was 16.8mmHg higher than themean at 9months
Table 1 – Demographic characteristics of study sample acc
18 months (complete case) or missed either follow-up visit
Characteristic Total
Count 416
Mean systolic blood pressure at baseline,
mm Hg (sd)
153 (16.8
Mean diastolic blood pressure at baseline,
mm Hg (sd)
86.0 (13.4
Age, mean (sd) 60.8 (11.6
Race, % (n)
Black non-Hispanic 59.1 (246)
Hispanic 36.5 (152)
Black Hispanic 4.33 (18)
Female, % (n) 70.9 (295)
Interviewed in Spanish, % (n) 30.8 (128)
Education, % (n)
High school 54.3 (226)
High school degree 27.2 (113)
High school 18.5 (77)
Inadequate health literacy, % (n) 43.5 (181)
Body mass index, % (n)
Normal 13.2 (55)
Overweight 28.6 (119)
Obese 58.2 (242)
Comorbidities
Alcohol abuse, % (n) 6.25 (26)
Coronary artery disease, % (n) 19.5 (81)
Diabetes, % (n) 51.4 (214)
Depression, % (n) 17.5 (73)
Psychiatric diseases, % (n) 12.7 (53)
Renal disease, % (n) 17.1 (71)
Blood pressure readings from charts
Systolic, mean (sd) 143 (20.5
Diastolic, mean (sd) 79.8 (12.6
No. of observations 3345
Pre-enrollment 314
0–9 mo 1725
9–18 mo 860
18 mo 446had a 33% probability (i.e., 1.5 times higher odds) of being assigned p“missing” at 9 months. We conducted simulations with values for
 of 0, log (1.25), and log (1.5).
For each simulation,we drewa randomvariable froma Bernoul-
li(Pˆim) distribution, and replaced the observed systolic blood pres-
ure for patient i at month m with a missing value if the Bernoulli
andom variable was equal to one. In each simulation 25% of the
bserved blood pressures were converted to missing values. This
ate of missing was similar to that observed in our trial and other
ypertension trials [15], and is the attrition rate at which pathol-
gies in imputationmethodologies have been shown to occur [10].
n sensitivity analyses, we also usedmissing data rates of 10% and
0% (available from the author).
We then created six estimates of the missing blood pressures:
wo were derived from ad hoc imputation methods and four from
egression-based methods. These are described in Table 3. The
wo ad hoc methods were last data carry forward (LDCF) and next
nd last (NAL). NAL imputes the missing 9-month blood pressure
ith the average of the baseline and 18 month, provided the 18-
onth data are available; otherwise it uses LDCF. We used two
egression methods (XB) and (XB  Cht) in which the predicted
alues of equations (2a) and (2b), respectively,were used to impute
he missing blood pressure. The two equations differ in that the
atter (XB Cht) includes the fitted value of the chart-based blood
g to if the patient returned for follow-up visits at 9 and
y missing).
Complete
case
Any
missing
P
264 152
151 (16.7) 156 (16.8) 0.015
85.0 (13.0) 87.9 (13.8) 0.028
60.9 (11.3) 60.5 (12.1) 0.731
0.063*
63.3 (167) 52.0 (79)
33.3 (88) 42.1 (64)
3.41 (9) 5.92 (9)
74.2 (196) 65.1 (99) 0.049
26.1 (69) 38.8 (59) 0.007
0.032
49.6 (131) 62.5 (95)
29.2 (77) 23.7 (36)
21.2 (56) 13.8 (21)
39.0 (103) 51.3 (78) 0.015
0.881
12.9 (34) 13.8 (21)
28.0 (74) 29.6 (45)
59.1 (156) 56.6 (86)
7.58 (20) 3.95 (6) 0.141
17.8 (47) 22.4 (34) 0.257
52.7 (139) 49.3 (75) 0.515
16.7 (44) 19.1 (29) 0.533
12.5 (33) 13.2 (20) 0.846
19.3 (51) 13.2 (20) 0.108
143 (20.7) 144 (20.3) 0.358
79.2 (12.6) 80.9 (12.7) 0.187
2232 1113
197 117
1139 586
594 266
302 144ordin
(An
)
)
)
)
)ressure as an additional covariate. In both cases, we added a
ressu
1088 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 0 8 5 – 1 0 9 1normal mean-zero random disturbance term with variance equal
to the estimated residual variances from (2a) and (2b), respec-
tively. Finally, we employed two methods based on a multiple
Table 2 – Comparison of least squares models of follow-up
respectively, as a function of baseline patient characteristi
pressure model (models 2b).
Systolic blood pressu
Model 2a M
 P 
Baseline systolic BP 0.270 0.000 0.099
Baseline diastolic BP 0.301 0.001 0.207
Month 18 0.400 0.776 0.112
Age 0.366 0.001 0.200
Female 0.314 0.908 2.004
Non-Hispanic black ref. ref.
Hispanic 0.492 0.889 2.198
Black Hispanic 9.593 0.175 6.062
Inadequate health
literacy
1.687 0.432 1.754
Interviewed in Spanish 1.146 0.758 2.157
 High school degree ref. ref.
High school degree 1.521 0.553 0.113
 High school degree 3.329 0.289 2.052
BMI-Normal ref. ref.
BMI-Overweight 1.070 0.756 0.999
BMI-Obese 1.710 0.599 2.697
Current smoker 0.059 0.981 0.435
Coronary artery disease 0.016 0.995 0.875
Alcohol abuse 6.254 0.129 3.921
Diabetes 4.162 0.053 3.830
Psychological disease 2.175 0.502 2.866
Renal disease 8.602 0.005 6.916
Fitted systolic chart BP 0.845
Fitted diastolic chart BP
Constant site effects 40.436 0.012 32.866
Adjusted R2 0.102 0.264
AIC 5242 5126
Subjects 416 416
Observations 587 587
Note: Fitted values are frommixed effects linear models of chart-bas
time  9 and 18 months. Models (2a) and (2b) are based on equations
AIC, Akaike information criterion; BMI, body mass index; BP, blood p
Table 3 – Description of alternative imputation algorithms
Imputation method Label
Ad hoc LDCF Last data carry
Ad hoc NAL Next and last.
next observ
Regression based single imputation XB Predicted valu
characterist
Additional v
variance eq
Regression based single imputation XBCht Similar to XB b
from a linea
time square
parameters
Multiple imputation MI Ten imputatio
Multiple imputation MICht Ten imputatioinclude the chartimputation algorithm: the first (MI) used the explanatory variables
in (2a) as explanatory variables and the second (MI Cht) used the
variables in (2b). For both, we created 10 imputations for each
l-based systolic and diastolic blood pressure,
odels 2a), and the fitted values from chart-based blood
Diastolic blood pressure
l 2b Model 2a Model 2b
P  P  P
0.193 0.065 0.140 0.056 0.176
0.008 0.405 0.000 0.185 0.000
0.936 0.850 0.286 0.846 0.281
0.038 0.221 0.000 0.159 0.003
0.371 2.077 0.133 1.619 0.166
ref. ref.
0.467 2.824 0.147 1.385 0.378
0.321 0.297 0.924 2.123 0.349
0.343 1.393 0.239 0.813 0.402
0.500 1.362 0.484 1.109 0.495
ref. ref.
0.960 0.140 0.923 0.771 0.515
0.438 1.220 0.491 0.713 0.648
ref. ref.
0.740 0.044 0.982 0.341 0.825
0.331 2.239 0.259 1.648 0.297
0.836 0.630 0.658 0.861 0.465
0.690 1.119 0.350 0.052 0.961
0.269 2.240 0.388 0.674 0.723
0.035 0.986 0.372 0.399 0.677
0.311 1.856 0.253 1.226 0.388
0.003 0.383 0.790 1.293 0.302
0.000
0.895 0.000
0.038 47.816 0.000 7.559 0.423
0.284 0.408
4525 4414
416 416
586 586
od pressure as a function of time since randomization, evaluated at
and (2b), respectively.
re.
.
Description
ard
verage of the last observed value before the missing value, and the
lue. If no next value exists, then LDCF is used.
a regression of trial-based blood pressures on baseline patient
lood pressure at baseline, and a dummy variable for month.
ce is added in the form of a mean zero normal disturbance with
the estimated variance of the regression error.
e regression includes as an additional covariate the fitted values
ed model of chart-based blood pressure as a function of time and
th patient specific random components to the intercept and time
sed on the regression model used to predict XB
sed on the regression model used to predict XB  Cht, whichtria
cs (m
re
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1089V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 0 8 5 – 1 0 9 1missing blood pressure value. We used the multiple imputation
algorithm “ice” in Stata 10 (2007, Stata Corp, College Station, TX) to
perform the imputations. The “ice” algorithm uses imputation by
chained equations, which has been shown to work well when
compared to the more classic imputation approach using imputa-
tions from Bayesian posterior distributions [16].
We compared the properties of the six models using bias
bias  1nYˆims  Yims  and the root mean squared deviation
MSD 1nYˆims Yims 2, where n is the number of individuals
ith “missing” and imputed blood pressures, Ysim is true systolic
lood pressure for individual i at follow-up month m, and Yˆsim is
ystolic blood pressure imputed by one of the sixmethods.We also
alculated the proportion of variance (PV  var(Yˆs)/var(Ys), where
var(Yˆs) was calculated using Rubin’s rule for the multiply imputed
estimates, and coverage, which is the proportion of times the confi-
dence interval for themean of the imputed blood pressures included
themean of the true blood pressures. Each simulation involved 1000
replications and was conducted using Stata 10.
Results: Simulation to Compare Imputation Methods that Incorporate
Chart-Based Data with Standard Imputation Methods
Figure 1 shows the simulation results for imputing systolic
blood pressure from 1000 replications where themissing data rate
was set at 25%. Results for diastolic blood pressure (not shown)
were similar to those for systolic; results for missing data rates of
10% and 40% were similar to those for 25% and are available from
the author. The logistic model of missingness at follow-up that
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Fig. 1 – Results of 1000 stimulations of the performance of si
terms of bias, root mean squared deviation (RMSD), and prowas used to estimate the coefficients in equation (3a) and effect bthe MAR and MNAR scenarios described below is also available
from the author.
Results when the data are missing at random In the simulations
that assumed aMARmissing datamechanism, the regression and
multiple imputation methods generated imputations that were
close on average to the true blood pressure measures, regardless
of whether fitted values from charts were used to generate the
imputation. However, incorporation of the chart-based fitted val-
ues led to lower RMSD for either the single imputation (RMSD for
XB  29 vs. XB  Cht  26) or the multiple imputation algorithm
RMSD for MI  30 vs. MI  Cht  27). The estimates derived from
ultiple imputation were overdispersed (proportionate variance
or MI  2.7; MI  Cht  2.4), but the MI and MI  Cht algorithms
achieved coverages that were closest to nominal (Table 4).
The two ad hoc imputation methods substantially overesti-
mated the true blood pressure (LDCF bias 9.8mmHg; NAL bias
.6 mm Hg), which should be expected given the downward trend
ver time in blood pressure in the trial. The proportionate variance
hows that the ad hoc estimates were somewhat under-dispersed
ompared to true values (proportionate variance for LDCF  0.81;
AL 0.77). The substantial bias and underdispersion caused very
oor coverage rates (Table 4).
Results when the data are missing not at random. When the miss-
ng data are MNAR, themodel-based estimates systematically im-
uted blood pressures that were biased downward as expected
Fig. 1); however, the versions of these methods that incorporate
he chart-based fitted values were less biased (e.g., for   log(1.5)
-3.7 -4.4 -3.7
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5.0
2.8
-8.1 -6.7 -8.2 -6.6
-2
0.
0
-1
0.
0
0.
0
10
.0
20
.0
LDCF NAL XB XB+Chrt MI MI+Chrt
Missing not at random: theta=log(1.5)
27
31
28
B+Chrt MI MI+Chrt
: theta=log(1.25)
25
23
31
28
31
28
20
25
30
35
LDCF NAL XB XB+Chrt MI MI+Chrt
Missing not at random: theta=log(1.5)
0.9
2.4 2.2
B+Chrt MI MI+Chrt
: theta=log(1.25)
0.8 0.7 0.8 0.8
2.1 1.9
0
1
2
3
4
5
6
LDCF NAL XB XB+Chrt MI MI+Chrt
Missing not at random: theta=log(1.5)
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1090 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) 1 0 8 5 – 1 0 9 1deviations (e.g., for  log(1.5) RMSD XB 31; XB Cht 28), and
roportionate variances that were marginally closer to unity.
The ad hoc methods were less biased under MNAR than under
AR but continued to impute blood pressure estimates that were
oo high, increasingly underdispersed, and had poor coverage
roperties. As discussed below, the biaswas smaller for the ad hoc
ethods under MNAR not because these techniques were supe-
ior but because of the way the MNAR scenarios were designed.
Discussion
Wedescribed a newmethod for using longitudinal data abstracted
from patients’ charts to impute data missing from a clinical trial,
and tested the method using data from a recently completed hy-
pertension trial. We tested a two-step process in which we first
estimated a longitudinal mixed model of the blood pressures ab-
stracted from patients charts as a function of time and patient-
specific random components to the intercept and time parame-
ters, and recovered estimates of the patient-specific fitted values
from this model on the day the patient was scheduled for a fol-
low-up visit at 9 and 18months after entry into the trial. This fitted
value is an estimate, according to data recorded in the patient
chart, of the patient’s blood pressure on the day he or she was
scheduled to return for a follow-up trial-based blood pressure
reading. In the second step we used these fitted values to impute
the missing trial-based blood pressures.
In simulations we found that this two-step process performed
marginally better than regression-based single or multiple impu-
tationmethods that did not incorporate the chart-based fitted val-
ues. Incorporating fitted values from charts into a regression-
based single or multiple imputation algorithm yielded estimates
with lower bias, lower mean squared deviation, and a proportion-
ate variance closer to unity than did other estimates, even in sim-
ulations where aMNARmissing datamechanismwas imposed. In
these latter simulations, incorporating the fitted values from
chart-based models ameliorated but did not eliminate the bias
that is inherent when data are MNAR.
The interpretation of the simulation results is more complex
for comparisons of ad hocmethods (such as LDCF) to the proposed
new method, but the interpretation still suggests the marginal
superiority of the newmethods. For simulation scenarios inwhich
the missing data are MAR, the novel method was clearly superior
to the ad hoc approaches, but this may be more a function of the
data we used than the methods. In the trial, blood pressures de-
creased over time so using the ad hoc method of imputing a miss-
ing follow-up blood pressurewith a baseline valuewould naturally
overestimate the follow-up blood pressure if the missing data are
MAR. In theMNAR scenario, these adhocmethods did not perform
as badly, but this was mostly a function of how we designed the
MNAR scenario. We assumed patients with high follow-up blood
pressures were more likely to be “missing” at follow-up. Thus, the
missing follow-up blood pressures were higher on average than
the observed follow-up blood pressures. Because baseline blood
pressures were also higher on average than observed follow-up
Table 4 – Results of 1000 simulations of the coverage of six
three missing data mechanisms. The nominal coverage is
Missing data mechanism LDCF NAL
Missing at random:   0 0.00 0.01
Missing not at random:   1.25 0.02 0.19
Missing not at random:   1.50 0.18 0.62
LDCF, last data carry forward; MI, multiple imputation; MI Cht, mul
imputation from regression; XB  Cht, single imputation from regresblood pressures, using baseline blood pressures to imputemissingblood pressures yields higher than average imputations, and con-
sequently lower than average bias. However, this findingwould be
precisely reversed if we had said that lower follow-up blood pres-
sures were more likely to be missing. Imputing lower-than-aver-
age follow-up blood pressures using higher-than-average baseline
blood pressures in an ad hoc procedure would have exacerbated
the missing data bias. Thus, choosing between an ad hoc method
that has been recommended by some other studies [9] and the
new methods developed here should best be made with a good
understanding of the trends in the observed data over time and a
reasonable conceptual model of why data are missing.
Our incorporation of chart-based data is similar to other data
enhancement techniques [5,17] inwhich data fromadministrative
databases were used to replace or enhance clinical databases. In
these studies, a potentially missing indicator for a risk factor for a
given study subject was coded as present if either administrative
or clinical data sources indicated that the risk factor was present
during the calendar year. Our study differs from these analyses in
that the timing of themeasurement was critical; simply averaging
chart-based blood pressure over a year would not capture the
downward trend in blood pressure observed in the trial. Other
studies that explored imputation of longitudinalmissing data [3,9]
have found better results by using a patient’s own data to impute
missing observations rather than using the cross sectional mean
of data from other patients. Our results are similar: using a pa-
tient’s own data abstracted from clinical charts proved useful for
predicting a patient’s missing trial-based data.
The mechanism by which the chart-based method improved
regression-based single or multiple imputation is fairly straight-
forward. The chart-based multilevel model included patient spe-
cific intercepts and patient-specific time trends, so that a predic-
tion of chart-based blood pressure for a particular patient on a
particular day could be derived regardless of whether or not a
patient had an outpatient visit on that day. These predicted chart-
based blood pressures were highly correlated with observed trial-
based blood pressures taken on that day. This is evidenced by a
regression of trial-based blood pressures on chart-based fitted val-
ues (equation (2b)) in which the coefficient on the chart-based
values was 0.845 and highly significant (P  0.001). This suggests
that for a patient who had a chart-based fitted value of blood pres-
sure 10mmHg higher than average at follow-up, wewould expect
an 8.45 mm Hg higher than average blood pressure if the patient
kept the follow-up appointment with trial personnel on that day.
The inclusion of chart-based fitted values in the regression re-
sulted in a greater than 2.5-fold increase in the regression’s ad-
justed R2. Because of this high correlation, the inclusion of these
fitted values led to better estimates of the missing trial-based
blood pressures.
In addition, because the chart-based fitted values are estimates
of what the missing blood pressure would have been had it been
measured in the trial, their inclusion in an imputation algorithm
helped to reduce the missing data bias in MNAR situations where
the probability of being missing was a function of the missing
blood pressure value. Other studies have found thatwhen data are
thods for imputing missing trial-based blood pressure, by
.
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scribed here also did not, but theymoved the point estimate in the
direction of less bias.
Researchers might be compelled to use simpler techniques to
incorporate data from charts, but these would not have been fea-
sible for our trial. For example, if a patient made a clinic visit on or
near the date of a scheduled follow-up trial visit, one might con-
sider simply using the chart-based blood pressure data from that
visit in place of the missing trial observation, but this simple so-
lution is complicated by two facts. In our trial relatively few pa-
tients (16 of 152) had outpatient visits within the protocol-speci-
fied window of the scheduled-but-missed trial follow-up visits. In
addition, the trial-based blood pressures were systematically
higher than the chart-based blood pressures, which implies that
simply substituting a chart-based blood pressure for a missing
trial observation would lead to biased estimates of the trial-based
blood pressure. The methods we describe overcome both of these
obstacles. By predicting chart-based blood pressure on the day of
themissed trial-basedmeasurement we overcame the problem of
timing, and by using the predicted chart-based blood pressure as a
regressor in an imputation equation, rather than as the imputa-
tion itself, we overcame the problem of the differences in levels
between trial- and chart-based blood pressures.
Recommendations
Althoughwe demonstrate themethods using blood pressure data,
these methods might be useful in many situations where impor-
tant variables are collected for a trial, and also collected as a part of
routinemedical care. Examples include vital statistics and lab val-
ues for patients with chronic diseases, which are routinely col-
lected and will become more easily assessable by trial personnel
as more outpatient clinics adopt electronic health records. If a
researcher wants to explore the use of these data for imputing trial
data we recommend three steps. First, estimate an equation similar
to equation (1) on the chart data, incorporating the powers of time
and patient-level random effects that make sense. Second, estimate
an equation similar to (2b) to see if the fitted values from (1) are
significant predictors of observed follow-up trial-based measures. If
they are, then using these fitted values in a regression-based impu-
tation algorithm is prudent. Third, estimate an equation similar to
(3c) below, in which the probability of being missing at follow-up is
modeled as a function of the fitted values from (1).
Pr(Missingim 1) logistic (a0 a1x1 a2Yi0
s  a3I18(m) a4Yˆim
c ) (3c)
If the fitted values were significant predictors of observed trial
data in (2b), then the coefficient on fitted values in (3c) provide a
test of the MAR assumption. A statistically significant coefficient
on the fitted values suggests that themissing datamight beMNAR,
and the sign of the coefficient indicates the direction of the miss-
ing data bias. In our data, this was a particularly weak test. In 1000
simulations with an MNAR of   log(1.5), this coefficient was sig-
ificant and negative in only 25 simulations, which is what one
ould expect by chance.
Limitations
Some important limitations should be noted. We imposed an
MNARmissing datamechanismondata thatwere in fact notmiss-
ing. It is not clear if the chart-based fitted values would be as
highly correlated with the blood pressures of patients who did not
return for a follow-up visit. We preformed this analysis using lin-
earmodels on blood pressure data that are normally distributed.
t is not clear if applying these methods using nonlinear models
nd non-normally distributed data would yield similar results.
hese methods would not be useful if missing follow-up data
ere caused by active withdrawal from a trial and a concomi-tant withdrawal of permission to use data abstracted from a
patient’s chart. Finally, we used only one multiple imputation
routine (the “ice” algorithm in Stata 10), although several alter-
native algorithms exist.
Conclusions
Chart-based blood pressuremeasurements can be effectively used
to imputemissing blood pressure data in a clinical trial. A two-step
process of estimating a longitudinal mixed model on the chart
data, and using the fitted values from this model as explanatory
variables in a regression-based imputation algorithm led to im-
puted blood pressure values with lower bias and smaller root
mean squared deviations than did imputation algorithms that did
not incorporate the chart-based blood pressures. This technique
might be useful for imputing a variety of longitudinal data that are
missing from a clinical trial but collected during routine clinical
visits outside the trial.
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